Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease
Clinical trial NCT06987695 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06987695
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-13
- Primary completion
- 2027-04-27
- Enrollment
- 279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.